Login / Signup

Cardiac myosin inhibitors for hypertrophic cardiomyopathy: Shedding light on their clinical potential.

Shiavax J RaoBeani ForstAmreen K KanwalArjun S KanwalWilbert S AronowSrihari S Naidu
Published in: Expert opinion on investigational drugs (2023)
Keyphrases
  • hypertrophic cardiomyopathy
  • left ventricular
  • heart failure
  • binding protein
  • risk assessment
  • atrial fibrillation